On May 17, the U.S. FDA authorized a booster of Pfizer’s vaccine for kids ages 5 to 11 years. The action comes as major cities are announcing a rise in cases. Additionally, COVID-19 would have claimed over 110,000 more lives in 2021 if not for the Pfizer-BioNTech vaccine, according to a Pfizer-sponsored report on the first year of the U.S. vaccination program.
Conference to Be Held May 19-23, 2018 in Baltimore, MD, USA Lawrenceville, NJ, USA—May 9, 2018—ISPOR, the professional society for health economics and outcomes research, released the final program and […]
Pharmaceutical marketers need to adapt to the value-centric marketplace and deliver the desired messaging and adjunctive, innovative services that align their products with the value perception the new marketplace demands.
ISPOR, the professional society for health economics and outcomes research, announced that registration is open for a new webinar that reviews the, “Top 10 Trends in Health Economics and Outcomes Research.”
